The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,870,684 in first-year total cost, median $974,750.
Most frequent study sections
- Special Emphasis Panel[ZAI1 JBS-A (J1)]3
Most frequent institutions
- HACKENSACK UNIVERSITY MEDICAL CENTER1
- METHODIST HOSPITAL RESEARCH INSTITUTE1
- RBHS-NEW JERSEY MEDICAL SCHOOL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection1R01AI161013-01 | GENGENBACHER, MARTIN ALFONSWILKINSON, ROBERT JOHN | HACKENSACK UNIVERSITY MEDICAL CENTER, NJ | $1,297,094 | ZAI1 |
| 2021 | Novel Stem Cell Immunotherapy for MDR-Tuberculosis1R01AI161015-01 | ENDSLEY, JANICE JJAGANNATH, CHINNASWAMYKHAN, ARSHAD | METHODIST HOSPITAL RESEARCH INSTITUTE, TX | $974,750 | ZAI1 |
| 2021 | Optimizing vaccine science to improve the outcome of tuberculosis treatment1R01AI161822-01 | SUBBIAN, SELVAKUMAR | RBHS-NEW JERSEY MEDICAL SCHOOL, NJ | $598,840 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.